SCHEMBL7700144

SCHEMBL7700144

N#Cc1ccc2c(c1)C1CC2CN(C(=O)O)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA1 P02708 1/20 0.55
CHRNG P07510 1/20 0.55
CHRNB1 P11230 1/20 0.55
CHRNB2 P17787 1/20 0.55
CHRNB4 P30926 1/20 0.55
CHRNA3 P32297 1/20 0.55
CHRNA4 P43681 1/20 0.55
CHRND Q07001 1/20 0.55
PTGDR2 Q9Y5Y4 1/20 0.46
GRIN2B Q13224 2/20 0.42
ALDH1A1 P00352 1/20 0.40
NOTUM Q6P988 1/20 0.39
USP30 Q70CQ3 3/20 0.38
FASN P49327 2/20 0.37
BRD4 O60885 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
MGLL Q99685 2/20 0.36
PAX8 Q06710 1/20 0.36
DRD2 P14416 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4409738 0.80 KDM4E (0.50) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL15544942 0.76 USP30 (0.54) ALDH1A1USP30FASN
SCHEMBL7694165 0.75 CHRNB2 (0.61) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
Hydrochloric Acid SCHEMBL6824751 0.74 CHRNB2 (0.58) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL5769083 0.72 GPR119 (0.49) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL16905570 0.71 CHRNA1 (0.65) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL4412259 0.71 CHRNB2 (1.00) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL16905238 0.71 CHRNA1 (0.59) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL16905466 0.71 CHRNA1 (0.64) CHRNA1CHRNGCHRNB1CHRNB2CHRNB4
SCHEMBL2225020 0.71 USP30 (0.59) PTGDR2ALDH1A1USP30FASN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020072525-A1 Aryl fused azapolycyclic compounds PFIZER INC 2002-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020072525-A1 Aryl fused azapolycyclic compounds GRIN2C, GRIN2A, GRIN2B CHRNA1 375/4885CHRNG 1914/4885CHRNB1 665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.